[Clinical application of beta-blockaders].
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D001008:Anxiety Disorders / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006980:Hyperthyroidism / Q000188:drug therapy; D010096:Oxprenolol / Q000627:therapeutic use; D010869:Pindolol / Q000627:therapeutic use; D011217:Practolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D010869:Pindolol; D011217:Practolol
Klinische toepassing van bèta-blokkeerders.